GeneMe

GeneMe

Warsaw, Poland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.5M

Overview

GeneMe is a Warsaw-based genetic diagnostics company providing personalized DNA analysis services directly to consumers. Operating since 2015, it leverages genetic testing to offer health predisposition, wellness, and ancestry reports, positioning itself in the growing European personalized medicine market. As a private entity, it likely follows a service-based revenue model, selling test kits and reports. The company's success hinges on its testing accuracy, data interpretation, marketing reach, and ability to navigate the evolving regulatory landscape for genetic data.

Diagnostics

Technology Platform

DNA genotyping via microarray and bioinformatic analysis pipeline for interpreting genetic variants related to health, wellness, and ancestry.

Funding History

1
Total raised:$1.5M
Seed$1.5M

Opportunities

The growing consumer interest in personalized health in Poland and Central Europe presents a significant expansion opportunity.
Partnering with corporate wellness programs, nutritionists, or fitness centers could provide a scalable B2B2C revenue stream.
Potential evolution into regulated clinical diagnostics under EU IVDR could open the healthcare provider market.

Risk Factors

Stringent and evolving EU regulations (IVDR, GDPR) pose compliance and cost challenges.
High competition from well-funded international DTC brands threatens market share.
Consumer misinterpretation of genetic risk data could lead to reputational damage and legal liability.

Competitive Landscape

GeneMe operates in a highly competitive DTC genetic testing market, competing against global giants like 23andMe and AncestryDNA, as well as other European players like MyHeritage and numerous local diagnostics labs. Differentiation is key and may be achieved through local market expertise, Polish-language support, and tailored reporting for the regional population.